Clinical efficacy of NovaSure for 30 patients with adenomyosis.
10.11817/j.issn.1672-7347.2016.01.014
- Author:
Dan LI
1
;
Yajun WAN
1
;
Qingling MU
2
Author Information
1. Department of Obstetrics and Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
2. Department of Obstetrics and Gynecology, Qingdao City Hospital, Qingdao Shandong 266071, China.
- Publication Type:Journal Article
- MeSH:
Adenomyosis;
surgery;
Dysmenorrhea;
surgery;
Endometrial Ablation Techniques;
methods;
Female;
Humans;
Menorrhagia;
surgery;
Retrospective Studies;
Treatment Outcome
- From:
Journal of Central South University(Medical Sciences)
2016;41(1):88-92
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the efficacy and safety of NovaSure system for dysmenorrhea and abnormal uterine bleeding of adenomyosis.
METHODS:A retrospective analysis on 30 patients with adenomyosis, who treated by NovaSure, were carried out. We collected related clinical data before operation and collected postoperative information about dyemenorrhea, menstruation, anemia and uterine volume by visiting outpatient or telephone.
RESULTS:All patients were followed up for 7 to 31 months after the operation. The relief rate of menstrual pain was 83.3%. All patients got obvious improvements in menstruation and anemia (P<0.05). After operation, uterine volume was significantly decreased (P<0.05). Only one case received intervention in 2 years (3.3%).
CONCLUSION:NovaSure can relieve symptoms of menorrhagia and alleviate dysmenorrhea symptoms. It is a new way for the treatment of uterine adenomyosis.
